Cargando…
The functional GRHL3-filaggrin axis maintains a tumor differentiation potential and influences drug sensitivity
Current therapies for treating heterogeneous cancers such as head and neck squamous cell carcinoma (HNSCC) are non-selective and are administered independent of response biomarkers. Therapy resistance subsequently emerges, resulting in increased cellular proliferation that is associated with loss of...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Gene & Cell Therapy
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8353142/ https://www.ncbi.nlm.nih.gov/pubmed/33775911 http://dx.doi.org/10.1016/j.ymthe.2021.03.016 |